Journal rankings · indicator year 2007
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2007
Immunology journal rankings 2007
72 ranked journals · Subfield in Immunology and Microbiology
Immunology has 72 ranked journals in 2007. The median OJR rose 0.07 on 2006 to 0.96, below the world average of 1.00; Q1 starts at OJR 1.24. The top three are Nature Immunology, Immunity, and The Journal of Experimental Medicine.
Ranks and citation indicators: 2007. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2004–2006, the window the 2007 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
72 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2006. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2004–2006, the window the 2007 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2004–2006 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2007. | Compare |
|---|---|---|---|---|---|---|---|
1Nature ImmunologyNature Portfolio · United States | 5.75Q1 | 17.71 0.95 down from 2006 | 676 | 19% | $12,690 | ||
2ImmunityCell Press · United States | 5.15Q1 | 15.54 0.56 down from 2006 | 530 | 100% | $10,400 | ||
3The Journal of Experimental MedicineRockefeller University Press · United States | 4.64Q1 | 14.12 0.01 up from 2006 | 1,152 | 92% | — | ||
4Annual Review of ImmunologyAnnual Reviews · United States | 2.70Q1 | 46.74 3.55 up from 2006 | 94 | 23% | — | ||
5Seminars in ImmunologyElsevier BV · United States | 2.53Q1 | 7.33 2.84 down from 2006 | 149 | 41% | $4,370 | ||
6Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.41Q1 | 6.90 0.21 down from 2006 | 1,514 | 48% | $4,900 | ||
7The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.03Q1 | 6.55 0.36 down from 2006 | 5,853 | 31% | $3,500 | ||
8The AAPS JournalSpringer Science+Business Media · United States | 1.87Q1 | 4.10 1.66 up from 2006 | 222 | 94% | $5,090 | ||
9Springer Seminars in ImmunopathologySpringer Science+Business Media · Germany | 1.75Q1 | 4.31 1.07 down from 2006 | 118 | — | — | ||
10Nature reviews. ImmunologyNature Portfolio · United Kingdom | 1.67Q1 | 12.40 1.13 up from 2006 | 687 | 5% | — | ||
11Journal of AutoimmunityElsevier BV · United Kingdom | 1.60Q1 | 5.38 2.73 up from 2006 | 237 | 27% | $5,420 | ||
12Genes and ImmunitySpringer Nature · United States | 1.56Q1 | 4.62 0.13 down from 2006 | 321 | 12% | $3,190 | ||
13Journal of Leukocyte BiologyOxford University Press · United States | 1.55Q1 | 4.55 0.05 down from 2006 | 905 | 14% | $3,800 | ||
14European Journal of ImmunologyWiley · Germany | 1.55Q1 | 4.81 0.15 down from 2006 | 1,119 | 67% | $4,550 | ||
15Critical Reviews in ImmunologyBegell House · United States | 1.49Q1 | 4.66 0.58 up from 2006 | 79 | 10% | — | ||
16Inflammation & Allergy - Drug TargetsBentham Science Publishers · Netherlands | 1.44Q1 | 2.73no 2006 value | 30 | 0% | — | — | |
17International ImmunologyOxford University Press · United Kingdom | 1.28Q1 | 3.12 1.18 down from 2006 | 520 | 37% | $3,530 | ||
18Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 1.24Q1 | 2.98 0.83 up from 2006 | 133 | 16% | $5,490 | ||
19Clinical ImmunologyElsevier BV · Netherlands | 1.22Q2 | 3.15 0.23 down from 2006 | 531 | 7% | $4,400 | ||
20Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.20Q2 | 3.12 0.05 up from 2006 | 432 | 2% | — | ||
21BioDrugsAdis, Springer Healthcare · Switzerland | 1.16Q2 | 2.96 0.31 down from 2006 | 113 | 8% | $5,190 | ||
22Immunity & AgeingOABioMed Central · United Kingdom | 1.16Q2 | 3.52 0.34 up from 2006 | 35 | 100% | $3,190 | ||
23ImmunologyWiley · United Kingdom | 1.16Q2 | 3.10 0.11 down from 2006 | 651 | 87% | $5,330 | ||
24Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.15Q2 | 3.09 0.02 down from 2006 | 895 | 95% | $3,816 | ||
25International Reviews of ImmunologyTaylor & Francis · United States | 1.13Q2 | 4.40 2.11 up from 2006 | 72 | 11% | — | ||
26Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 1.10Q2 | 11.93 1.17 up from 2006 | 142 | 29% | $4,900 | ||
27Molecular ImmunologyElsevier BV · Netherlands | 1.07Q2 | 3.01 0.32 down from 2006 | 845 | 15% | $3,340 | ||
28Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.06Q2 | 3.26 0.22 down from 2006 | 201 | 22% | $4,990 | ||
29BMC ImmunologyOABioMed Central · United Kingdom | 1.04Q2 | 3.04 0.73 down from 2006 | 76 | 100% | $3,090 | ||
30Immunology and Cell BiologyWiley · Australia | 1.03Q2 | 3.09 0.45 up from 2006 | 284 | 31% | $3,750 | ||
31Journal of Endotoxin ResearchManey Publishing · United Kingdom | 1.03Q2 | 2.97 0.36 up from 2006 | 263 | 29% | — | ||
32Immunologic ResearchSpringer Science+Business Media · United States | 1.01Q2 | 2.92 0.24 up from 2006 | 185 | 12% | $2,890 | ||
33ImmunobiologyOAElsevier BV · Germany | 1.01Q2 | 3.04 1.01 up from 2006 | 213 | 42% | $2,840 | ||
34Journal of Reproductive ImmunologyElsevier BV · Netherlands | 1.00Q2 | 2.57 0.14 up from 2006 | 203 | 7% | $3,690 | ||
35Human ImmunologyElsevier BV · United States | 0.97Q2 | 2.89 0.18 up from 2006 | 457 | 4% | $3,600 | ||
36ImmunogeneticsSpringer Science+Business Media · Germany | 0.97Q2 | 2.95 0.09 down from 2006 | 355 | 16% | $2,890 | ||
37Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.95Q3 | 2.75 0.15 up from 2006 | 273 | 8% | — | ||
38CytokineElsevier BV · United Kingdom | 0.94Q3 | 2.42 0.31 down from 2006 | 474 | 7% | $3,220 | ||
39Journal of Immunological MethodsElsevier BV · Netherlands | 0.94Q3 | 2.15 0.44 down from 2006 | 672 | 26% | $2,970 | ||
40Veterinary Immunology and ImmunopathologyElsevier BV · Netherlands | 0.91Q3 | 2.20 0.22 up from 2006 | 610 | 10% | $3,250 | ||
41Immunology LettersElsevier BV · Netherlands | 0.90Q3 | 2.72 0.41 up from 2006 | 557 | 16% | $3,290 | ||
42Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 0.90Q3 | 2.88 0.22 up from 2006 | 304 | 16% | $3,340 | ||
43Toxicologic PathologySAGE Publishing · United States | 0.86Q3 | 2.38 0.54 up from 2006 | 362 | 33% | $4,150 | ||
44Trends in ImmunologyElsevier BV · United Kingdom | 0.84Q3 | 10.22 0.76 down from 2006 | 321 | 15% | $7,030 | ||
45Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.82Q3 | 2.02 0.07 down from 2006 | 500 | 58% | $4,480 | ||
46Immunological ReviewsWiley · United States | 0.82Q3 | 12.36 0.16 up from 2006 | 364 | 11% | $5,000 | ||
47American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.75Q3 | 2.27 0.37 up from 2006 | 316 | 17% | $4,460 | ||
48Cellular ImmunologyElsevier BV · Netherlands | 0.71Q3 | 2.05 0.16 up from 2006 | 314 | 36% | $3,550 | ||
49International Journal of ImmunogeneticsWiley · United Kingdom | 0.67Q3 | 1.87 0.39 down from 2006 | 149 | 15% | $2,900 | ||
50Journal of Fish DiseasesWiley · United Kingdom | 0.64Q3 | 2.01 0.22 up from 2006 | 265 | 13% | $5,450 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2007. Corpus-wide, 72.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
12 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2004–2006, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2007. Publication window: 2004–2006. How these summaries are calculated
- Ranked journals
- 72
- Window papers (baseline)
- 50,960 +21.1% from indicator year 2004
- Median OJR
- 0.959 +15.5% from indicator year 2004
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2004–2006 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.